Literature DB >> 23045573

Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211.

Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi, Naoki Ishizuka, Yukio Kobayashi, Yasushi Isobe, Kenichi Ishizawa, Nobuo Maseki, Kuniaki Itoh, Noriko Usui, Izumi Wasada, Tomohiro Kinoshita, Tomomitsu Hotta, Kunihiro Tsukasaki, Kazuo Oshimi.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23045573     DOI： 10.1200/JCO.2012.45.6541

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  41 in total

1.  Novel therapies for peripheral T-cell lymphomas.

Authors:  Andrei Shustov
Journal:  Ther Adv Hematol       Date:  2013-06

2.  Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma.

Authors:  Yi-Yun Yao; Yong Tang; Yan Zhuang; Li-Fang Zou; Hong-Ju Dou; Lei Wang; Qi Zhu
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-19       Impact factor: 0.900

Review 3.  NK/T Cell Lymphoma: Updates in Therapy.

Authors:  Ritsuro Suzuki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

4.  First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG.

Authors:  Shu-Nan Qi; Yong Yang; Yu-Qin Song; Ying Wang; Xia He; Chen Hu; Li-Ling Zhang; Gang Wu; Bao-Lin Qu; Li-Ting Qian; Xiao-Rong Hou; Fu-Quan Zhang; Xue-Ying Qiao; Hua Wang; Gao-Feng Li; Hui-Qiang Huang; Yu-Jing Zhang; Yuan Zhu; Jian-Zhong Cao; Jun-Xin Wu; Tao Wu; Su-Yu Zhu; Mei Shi; Li-Ming Xu; Zhi-Yong Yuan; Hang Su; Jun Zhu; Ye-Xiong Li
Journal:  Blood Adv       Date:  2020-07-14

5.  First-line combination of GELOX followed by radiation therapy for patients with stage IE/IIE ENKTL: An updated analysis with long-term follow-up.

Authors:  Liang Wang; Zhi-Hui Wang; Xiao-Qin Chen; Ke-Feng Wang; Hui-Qiang Huang; Zhong-Jun Xia
Journal:  Oncol Lett       Date:  2015-06-05       Impact factor: 2.967

6.  Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience.

Authors:  Yukiko Hattori; Taro Murai; Hiromitsu Iwata; Kaoru Uchiyama; Mikio Mimura; Eriko Kato; Rumi Murata; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2016-02-06       Impact factor: 2.374

7.  Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.

Authors:  N Nora Bennani; Aung M Tun; Kenneth R Carson; Jessica L Geiger; Lauren S Maeda; Kerry J Savage; Jim Rose; Lauren Pinter-Brown; Matthew A Lunning; Jeremy S Abramson; Nancy L Bartlett; Julie M Vose; Andrew M Evens; Sonali M Smith; Steven M Horwitz; Stephen M Ansell; Ranjana H Advani
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2021-10-16

Review 8.  Current and future management of NK/T-cell lymphoma based on clinical trials.

Authors:  Motoko Yamaguchi
Journal:  Int J Hematol       Date:  2012-10-17       Impact factor: 2.490

Review 9.  Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas.

Authors:  Jason Yongsheng Chan; Soon Thye Lim
Journal:  Int J Hematol       Date:  2018-01-29       Impact factor: 2.490

10.  Controlling distant metastasis and surgical treatment are crucial for improving clinical outcome in uncommon head and neck malignancies, such as non-squamous cell carcinoma.

Authors:  Masashi Shiiba; Motoharu Unozawa; Morihiro Higo; Yukinao Kouzu; Atsushi Kasamatsu; Yosuke Sakamoto; Katsunori Ogawara; Katsuhiro Uzawa; Yuichi Takiguchi; Hideki Tanzawa
Journal:  Mol Clin Oncol       Date:  2014-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.